209 related articles for article (PubMed ID: 15763444)
1. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?
Johansen JS; Milman N; Hansen M; Garbarsch C; Price PA; Graudal N
Respir Med; 2005 Apr; 99(4):396-402. PubMed ID: 15763444
[TBL] [Abstract][Full Text] [Related]
2. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
[TBL] [Abstract][Full Text] [Related]
3. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker.
Kruit A; Grutters JC; Ruven HJ; van Moorsel CC; van den Bosch JM
Respir Med; 2007 Jul; 101(7):1563-71. PubMed ID: 17236752
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA
Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis.
Furuhashi K; Suda T; Nakamura Y; Inui N; Hashimoto D; Miwa S; Hayakawa H; Kusagaya H; Nakano Y; Nakamura H; Chida K
Respir Med; 2010 Aug; 104(8):1204-10. PubMed ID: 20347285
[TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease.
Erzin Y; Uzun H; Karatas A; Celik AF
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e357-62. PubMed ID: 17725598
[TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.
Vind I; Johansen JS; Price PA; Munkholm P
Scand J Gastroenterol; 2003 Jun; 38(6):599-605. PubMed ID: 12825867
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of YKL-40 increases in patients with acute myocardial infarction.
Nøjgaard C; Høst NB; Christensen IJ; Poulsen SH; Egstrup K; Price PA; Johansen JS
Coron Artery Dis; 2008 Jun; 19(4):257-63. PubMed ID: 18480670
[TBL] [Abstract][Full Text] [Related]
9. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
[TBL] [Abstract][Full Text] [Related]
10. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M
J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121
[TBL] [Abstract][Full Text] [Related]
11. YKL-40 levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: preliminary results.
Kaynar MY; Tanriverdi T; Kafadar AM; Kacira T; Yurdakul F; Uzun H; Gumustas K
J Clin Neurosci; 2005 Sep; 12(7):754-7. PubMed ID: 16153848
[TBL] [Abstract][Full Text] [Related]
12. High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia.
Bergmann OJ; Johansen JS; Klausen TW; Mylin AK; Kristensen JS; Kjeldsen E; Johnsen HE
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8644-52. PubMed ID: 16361549
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
[TBL] [Abstract][Full Text] [Related]
14. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
[TBL] [Abstract][Full Text] [Related]
16. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.
Kronborg G; Ostergaard C; Weis N; Nielsen H; Obel N; Pedersen SS; Price PA; Johansen JS
Scand J Infect Dis; 2002; 34(5):323-6. PubMed ID: 12069012
[TBL] [Abstract][Full Text] [Related]
17. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 levels are altered in endometriosis.
Tuten A; Kucur M; Imamoglu M; Oncul M; Acikgoz AS; Sofiyeva N; Ozturk Z; Kaya B; Oral E
Gynecol Endocrinol; 2014 May; 30(5):381-4. PubMed ID: 24533749
[TBL] [Abstract][Full Text] [Related]
19. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of YKL-40 in patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Dimoulios P; Vardas E; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
Int J Colorectal Dis; 2003 May; 18(3):254-9. PubMed ID: 12673492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
